Testing effectiveness (Phase 2)Study completedNCT00754494
What this trial is testing
Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma
Who this might be right for
Adenomatous PolypRecurrent Colon CancerRecurrent Rectal Cancer+14 more
National Cancer Institute (NCI) 45